MONROVIA, Calif., Nov. 3 /PRNewswire-FirstCall/ -- STAAR Surgical Company , a leading developer, manufacturer and marketer of minimally invasive ophthalmic products, today announced that it has been invited to present at the CIBC World Markets Fifteenth Annual Healthcare Conference at the Plaza Hotel in New York City on Tuesday, November 9th. The Company is scheduled to discuss its business strategy and historical financial performance at 4:00 p.m. Eastern Time.
Attendance at the conference is by invitation only. STAAR Surgical will offer a live audio-only webcast of its presentation which may be accessed at STAAR’s website at http://www.staar.com/. An archived replay of the presentation will also be available immediately following at the company’s website.
About STAAR Surgical
STAAR Surgical is a leader in the development, manufacture and marketing of minimally invasive ophthalmic products employing proprietary technologies. STAAR’s products are used by ophthalmic surgeons and include the revolutionary VISIAN ICL(TM) as well as innovative products designed to improve patient outcomes for cataracts and glaucoma. STAAR’s ICL has received CE Marking, is approved for sale in 37 countries and has been implanted in more than 35,000 eyes worldwide. It is currently under review by the FDA for use in the United States.
CONTACT: Investors Media EVC Group EVC Group Douglas Sherk, Sheryl Seapy, 415-896-6820 415-272-3323 Jennifer Beugelmans, 415-896-6820
STAAR Surgical Company
CONTACT: Investors, Douglas Sherk, +1-415-896-6820, or JenniferBeugelmans, +1-415-896-6820; or Media, Sheryl Seapy, +1-415-272-3323, all ofEVC Group, for STAAR Surgical
Web site: http://www.staar.com/